UBS Group AG - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 33 filers reported holding RANI THERAPEUTICS HLDGS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2023$12,398
-25.0%
5,700
+42.1%
0.00%
Q2 2023$16,529
+220.3%
4,012
+301.2%
0.00%
Q1 2023$5,160
-12.5%
1,0000.0%0.00%
Q4 2022$5,900
-41.0%
1,0000.0%0.00%
Q3 2022$10,000
-61.5%
1,000
-60.6%
0.00%
Q2 2022$26,000
-45.8%
2,538
-28.9%
0.00%
Q1 2022$48,000
-43.5%
3,570
-31.2%
0.00%
Q4 2021$85,000
+54.5%
5,191
+69.1%
0.00%
Q3 2021$55,0003,0700.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$6,663,0003.16%
LASRY MARC 62,828$848,0000.42%
Alphabet Inc. 714,471$9,645,0000.31%
Alpha Square Group S LLC 101,603$1,372,0000.19%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$6,498,0000.12%
STIFEL FINANCIAL CORP 41,900$566,0000.00%
OSAIC HOLDINGS, INC. 19,343$261,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 71,266$962,0000.00%
STATE STREET CORP 26,142$353,0000.00%
MILLENNIUM MANAGEMENT LLC 32,525$439,0000.00%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders